The Implantable Miniature Telescope (IMT) for End-Stage Age-Related Macular Degeneration

By Maureen A. Duffy, M.S., CVR

After completing a five-year testing period, the U.S. Food and Drug Administration (FDA) approved the Implantable Miniature Telescope (IMT) in 2010. Now, over a decade later, a study is underway to test a new version of the IMT, the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT™). The SING IMT™ is not a cure for late-stage AMD, but it can magnify what a person with late-stage, age-related macular degeneration (AMD) sees.  There are risks, however.

Learn more about age-related macular degeneration (AMD) at Macular Degeneration: An Overview by Lylas G. Mogk, MD.